BELSOMRA

Merck Canada Inc🇨🇦 Health Canada

Approval Id: 40366cdf64e4ad90
Drug Approval Canada Name: BELSOMRA
Product Name: BELSOMRA
Status: Cancelled Post Market
Status Date: 2020-05-14
Original Market Date: 2019-04-18
Din: 02483548
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:24.92
Atc Original: N05CJ01 SUVOREXANT
Atc Name: n 05 cj 01
Aig Number: 0160930004
Company Name: Merck Canada Inc
Company Address: 16750 Route Transcanadienne, Kirkland, Quebec, Canada, H9H 4M7

SUVOREXANT

20 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

40366cdf64e4ad90

Type

Standard